Cargando…

Observational study of feasibility and acceptability of the levonorgestrel-releasing intrauterine device as a long-acting reversible contraceptive in a primary care setting in India

OBJECTIVES: The levonorgestrel-releasing intrauterine device (LNG-IUD) is a well-accepted contraceptive across developed countries, yet there is limited experience in use and acceptance amongst women living in low-resource, developing country settings. We studied the feasibility of providing the LNG...

Descripción completa

Detalles Bibliográficos
Autores principales: Iyengar, Sharad, Iyengar, Kirti, Anand, Ankit, Suhalka, Virendra, Jain, Manju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287359/
https://www.ncbi.nlm.nih.gov/pubmed/35856048
http://dx.doi.org/10.1016/j.conx.2022.100079
_version_ 1784748236130484224
author Iyengar, Sharad
Iyengar, Kirti
Anand, Ankit
Suhalka, Virendra
Jain, Manju
author_facet Iyengar, Sharad
Iyengar, Kirti
Anand, Ankit
Suhalka, Virendra
Jain, Manju
author_sort Iyengar, Sharad
collection PubMed
description OBJECTIVES: The levonorgestrel-releasing intrauterine device (LNG-IUD) is a well-accepted contraceptive across developed countries, yet there is limited experience in use and acceptance amongst women living in low-resource, developing country settings. We studied the feasibility of providing the LNG-IUD through a primary care service, and its acceptability amongst women living in a low-income, rural-tribal community in India. STUDY DESIGN: We conducted an observational study of feasibility and acceptability at four health facilities (three rural, and one urban) in Rajasthan, India. Women seeking contraception were offered the LNG-IUD in addition to existing contraceptive methods. We followed all those who adopted LNG-IUD from August 2015 to September 2019 (n= 1266) till discontinuation or 12 months, whichever was earlier. The primary outcome was continuation rate and acceptability, and the secondary outcome was change in hemoglobin levels, which we measured before insertion and at 12-month follow-up, using Sahli's method. RESULTS: Most users lived in villages, were illiterate, belonged to marginalized groups, had 2 or more children, and wished to limit births when they adopted the method. The 12-month continuation rate was 87.6%. Amongst all users, 7.4% of women sought removal for side effects and 2% for change in reproductive intention, while another 2% reported spontaneous expulsion. Most continuing users reported hypomenorrhea (54%) or amenorrhea (42%) by 12 months of use. User satisfaction was high at 91.6%, with 92% of women rating their experience as equaling or exceeding expectations. Moderate and severe anemia reduced, and mean hemoglobin levels increased by 0.7 g/dL (p < 0.01). CONCLUSION: Primary care clinics can feasibly deliver LNG-IUD, with high acceptability amongst women living in low resource settings. Given the paucity of long-acting reversible contraceptive options and high prevalence of anemia among women in India and similar countries, the method should be piloted through the public health system. IMPLICATIONS: Long duration of contraceptive action, ability to reduce menstrual bleeding and reduce anemia, reversibility, and easy removal, combine to make LNG-IUD acceptable to women, especially in regions with high prevalence of anemia. This study demonstrates the feasibility and acceptability of introducing LNG-IUD in a low resource, primary care setting.
format Online
Article
Text
id pubmed-9287359
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-92873592022-07-17 Observational study of feasibility and acceptability of the levonorgestrel-releasing intrauterine device as a long-acting reversible contraceptive in a primary care setting in India Iyengar, Sharad Iyengar, Kirti Anand, Ankit Suhalka, Virendra Jain, Manju Contracept X Original Research Article OBJECTIVES: The levonorgestrel-releasing intrauterine device (LNG-IUD) is a well-accepted contraceptive across developed countries, yet there is limited experience in use and acceptance amongst women living in low-resource, developing country settings. We studied the feasibility of providing the LNG-IUD through a primary care service, and its acceptability amongst women living in a low-income, rural-tribal community in India. STUDY DESIGN: We conducted an observational study of feasibility and acceptability at four health facilities (three rural, and one urban) in Rajasthan, India. Women seeking contraception were offered the LNG-IUD in addition to existing contraceptive methods. We followed all those who adopted LNG-IUD from August 2015 to September 2019 (n= 1266) till discontinuation or 12 months, whichever was earlier. The primary outcome was continuation rate and acceptability, and the secondary outcome was change in hemoglobin levels, which we measured before insertion and at 12-month follow-up, using Sahli's method. RESULTS: Most users lived in villages, were illiterate, belonged to marginalized groups, had 2 or more children, and wished to limit births when they adopted the method. The 12-month continuation rate was 87.6%. Amongst all users, 7.4% of women sought removal for side effects and 2% for change in reproductive intention, while another 2% reported spontaneous expulsion. Most continuing users reported hypomenorrhea (54%) or amenorrhea (42%) by 12 months of use. User satisfaction was high at 91.6%, with 92% of women rating their experience as equaling or exceeding expectations. Moderate and severe anemia reduced, and mean hemoglobin levels increased by 0.7 g/dL (p < 0.01). CONCLUSION: Primary care clinics can feasibly deliver LNG-IUD, with high acceptability amongst women living in low resource settings. Given the paucity of long-acting reversible contraceptive options and high prevalence of anemia among women in India and similar countries, the method should be piloted through the public health system. IMPLICATIONS: Long duration of contraceptive action, ability to reduce menstrual bleeding and reduce anemia, reversibility, and easy removal, combine to make LNG-IUD acceptable to women, especially in regions with high prevalence of anemia. This study demonstrates the feasibility and acceptability of introducing LNG-IUD in a low resource, primary care setting. Elsevier 2022-06-30 /pmc/articles/PMC9287359/ /pubmed/35856048 http://dx.doi.org/10.1016/j.conx.2022.100079 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research Article
Iyengar, Sharad
Iyengar, Kirti
Anand, Ankit
Suhalka, Virendra
Jain, Manju
Observational study of feasibility and acceptability of the levonorgestrel-releasing intrauterine device as a long-acting reversible contraceptive in a primary care setting in India
title Observational study of feasibility and acceptability of the levonorgestrel-releasing intrauterine device as a long-acting reversible contraceptive in a primary care setting in India
title_full Observational study of feasibility and acceptability of the levonorgestrel-releasing intrauterine device as a long-acting reversible contraceptive in a primary care setting in India
title_fullStr Observational study of feasibility and acceptability of the levonorgestrel-releasing intrauterine device as a long-acting reversible contraceptive in a primary care setting in India
title_full_unstemmed Observational study of feasibility and acceptability of the levonorgestrel-releasing intrauterine device as a long-acting reversible contraceptive in a primary care setting in India
title_short Observational study of feasibility and acceptability of the levonorgestrel-releasing intrauterine device as a long-acting reversible contraceptive in a primary care setting in India
title_sort observational study of feasibility and acceptability of the levonorgestrel-releasing intrauterine device as a long-acting reversible contraceptive in a primary care setting in india
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287359/
https://www.ncbi.nlm.nih.gov/pubmed/35856048
http://dx.doi.org/10.1016/j.conx.2022.100079
work_keys_str_mv AT iyengarsharad observationalstudyoffeasibilityandacceptabilityofthelevonorgestrelreleasingintrauterinedeviceasalongactingreversiblecontraceptiveinaprimarycaresettinginindia
AT iyengarkirti observationalstudyoffeasibilityandacceptabilityofthelevonorgestrelreleasingintrauterinedeviceasalongactingreversiblecontraceptiveinaprimarycaresettinginindia
AT anandankit observationalstudyoffeasibilityandacceptabilityofthelevonorgestrelreleasingintrauterinedeviceasalongactingreversiblecontraceptiveinaprimarycaresettinginindia
AT suhalkavirendra observationalstudyoffeasibilityandacceptabilityofthelevonorgestrelreleasingintrauterinedeviceasalongactingreversiblecontraceptiveinaprimarycaresettinginindia
AT jainmanju observationalstudyoffeasibilityandacceptabilityofthelevonorgestrelreleasingintrauterinedeviceasalongactingreversiblecontraceptiveinaprimarycaresettinginindia